drugset / Trial / NCT01362959

Nicotine Replacement Therapy in the Intensive Care Unit

NCT01362959

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether transdermal nicotine replacement therapy is safe and effective for treating nicotine withdrawal symptoms in the critically ill smoking patient.

Timeline

Start
2012-06
Primary completion
2016-08
Completion
2016-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotine Unknown 14 mg Other
Subject Nicotine Unknown 21 mg Other